Provided by Tiger Trade Technology Pte. Ltd.

LEPU BIO-B

4.570
-0.070-1.51%
Volume:415.00K
Turnover:1.88M
Market Cap:8.24B
PE:-18.78
High:4.580
Open:4.580
Low:4.460
Close:4.640
52wk High:10.500
52wk Low:2.900
Shares:1.80B
HK Float Shares:1.80B
Volume Ratio:0.18
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.243
ROE:-24.53%
ROA:-3.93%
PB:9.77
PE(LYR):-18.78
PS:10.39

Loading ...

Lepu Biopharma Co., Ltd.'s (HKG:2157) Low P/S No Reason For Excitement

Simply Wall St.
·
Feb 11

Lepu Biopharma (02157) Releases Monthly Return Showing Unchanged Share Capital

Bulletin Express
·
Feb 05

HK Movers | Innovative Drug Stocks Jump With TYK Medicines up 14%

Tiger Newspress
·
Jan 07

Lepu Biopharma Announces Licensing Transaction Update

Reuters
·
Dec 18, 2025

Lepu Biopharma Co. Ltd. held second extraordinary general meeting

Reuters
·
Dec 18, 2025

HKD 360 Billion Wiped Out! "Consumer Trio" Plunges Sharply

Deep News
·
Dec 09, 2025

Lepu Biopharma (SEHK:2157): Valuation Check After New GLP-1 CDMO Framework Deal With Lepu Medical

Simply Wall St.
·
Dec 05, 2025

Lepu Biopharma (02157) Reports Unchanged Share Capital for November 2025

Bulletin Express
·
Dec 04, 2025

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03, 2025

Lepu Biopharma (2157) Announces Proxy Arrangements for 2025 Second EGM

Bulletin Express
·
Nov 28, 2025

Lepu Biopharma (2157) Proposes New RSU Scheme and Sets Date for Second 2025 EGM

Bulletin Express
·
Nov 28, 2025

Lepu Biopharma Co. Ltd. Announces Date for Second 2025 EGM Meeting

Reuters
·
Nov 28, 2025

LEPU BIO-B (02157) Enters into CDMO Service Framework Agreement with Lepu Medical

Stock News
·
Nov 28, 2025

Lepu Biopharma (2157) Announces New Procurement Framework Agreement with Lepu Medical (300003)

Bulletin Express
·
Nov 28, 2025

Lepu Biopharma (2157) Announces Continuing Connected Transaction with Lepu Medical

Bulletin Express
·
Nov 28, 2025

Lepu Biopharma Signs New Procurement Framework Agreement with Lepu Medical

Reuters
·
Nov 28, 2025

MEIYOUHENG Wins NMPA Approval as World’s First EGFR-Targeting ADC from TOT BIOPHARM, BioDlink, and Lepu Biopharma

Reuters
·
Nov 21, 2025

Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast

Stock News
·
Nov 18, 2025

Lepu Biopharma (SEHK:2157): Valuation in Focus After Landmark EGFR-Targeted ADC Approval

Simply Wall St.
·
Nov 12, 2025

HK Stock Connect Shareholding Changes | Nov 11

Stock News
·
Nov 11, 2025